International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 3 (May-June 2026) Submit your research before last 3 days of June to publish your research paper in the issue of May-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 3
May-June 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Probiotic Supplementation in the Prevention of Necrotizing Enterocolitis in Preterm Neonates

Author(s) Dr. Suchith Boodgere Suresh, Dr. Aruna Misir
Country India
Abstract Abstract
Necrotizing enterocolitis (NEC) is one of the most devastating gastrointestinal emergencies in preterm neonates, particularly those with very low birth weight (VLBW, <1,500 g). It is characterized by inflammation and necrosis of the intestinal wall, often leading to perforation, sepsis, and death. Despite advances in neonatal intensive care, mortality from NEC remains as high as 20–30%, and survivors frequently suffer from long-term complications such as short bowel syndrome and neurodevelopmental delay. Disruption of the intestinal microbiota and impaired mucosal immunity are key contributors to its pathogenesis. Probiotic supplementation, by introducing beneficial microbial strains, has been proposed as a preventive strategy that can modulate gut colonization, enhance mucosal barrier integrity, and downregulate pro-inflammatory responses.
Objective:
This study aimed to systematically evaluate the efficacy and safety of probiotic supplementation in preventing NEC in preterm neonates, with a focus on clinical outcomes including NEC incidence, mortality, and sepsis.
Methods:
A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was performed from inception to [Month, Year]. Eligible studies included randomized controlled trials (RCTs) and observational studies comparing probiotic supplementation with placebo or standard care in preterm neonates (<37 weeks’ gestation). The primary outcome was incidence of NEC stage II or higher (Bell’s criteria). Secondary outcomes included all-cause mortality, late-onset sepsis, feeding intolerance, duration of hospitalization, and adverse events. Data extraction was performed independently by two reviewers. Risk of bias was assessed using the Cochrane tool for RCTs and the Newcastle–Ottawa Scale for observational studies. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses were conducted based on probiotic strain (single vs multi-strain), birth weight categories (extremely low birth weight vs very low birth weight), and geographical setting (developed vs developing countries).
Results:
Twenty-seven RCTs encompassing 6,655 preterm neonates (3,298 probiotic vs 3,357 control) showed a significant reduction in NEC incidence (RR 0.35; 95% CI 0.27–0.44; P < 0.00001) and overall mortality (RR 0.58; 95% CI 0.46–0.75; P < 0.0001). No increase in sepsis risk was observed (RR 0.94; 95% CI 0.83–1.06; P = 0.31). An updated meta-analysis of 70 studies (8,319 cases and 9,283 controls) corroborated these findings, showing NEC reduction (RR 0.436; 95% CI 0.357–0.531; P < 0.001) and lower overall mortality (RR 0.651; 95% CI 0.506–0.836; P < 0.001), as well as NEC-related mortality (RR 0.639; 95% CI 0.423–0.966; P = 0.034). A network meta-analysis of 51 RCTs (11,661 infants) found that multi-strain combinations (e.g., Bifidobacterium + Lactobacillus + Streptococcus) significantly reduced mortality and NEC incidence, with striking efficacy (RR for combination including Streptococcus: 0.17; 95% CI 0.00–0.84)
Conclusion:
Probiotic supplementation appears to be a safe and effective intervention for reducing the incidence of NEC and all-cause mortality in preterm neonates, particularly when multi-strain preparations are used. However, variability in probiotic strains, dosages, initiation timing, and study methodologies highlights the need for standardized, large-scale, multicenter RCTs to establish universal clinical guidelines. Until then, cautious adoption with strain-specific consideration may be warranted in neonatal intensive care practice.
Keywords Probiotics, necrotizing enterocolitis, preterm neonates, very low birth weight, neonatal sepsis, systematic review, meta-analysis
Field Biology
Published In Volume 7, Issue 4, July-August 2025
Published On 2025-08-29
DOI https://doi.org/10.36948/ijfmr.2025.v07i04.54018
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 1Cover Page Vol 7 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals